SMALL LYMPHOCYTIC LEUKEMIA (SLL)
Clinical trials for SMALL LYMPHOCYTIC LEUKEMIA (SLL) explained in plain language.
Never miss a new study
Get alerted when new SMALL LYMPHOCYTIC LEUKEMIA (SLL) trials appear
Sign up with your email to follow new studies for SMALL LYMPHOCYTIC LEUKEMIA (SLL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cocktail aims to tame recurrent blood cancer
Disease control Recruiting nowThis study tests whether a combination of three drugs (pirtobrutinib, venetoclax, and obinutuzumab) can control chronic lymphocytic leukemia or small lymphocytic lymphoma that has come back after prior treatment. About 40 adults with relapsed CLL/SLL will receive this time-limite…
Matched conditions: SMALL LYMPHOCYTIC LEUKEMIA (SLL)
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 04:36 UTC
-
Triple-Drug attack aims to wipe out CLL and SLL
Disease control Recruiting nowThis study tests whether a combination of three drugs (zanubrutinib, obinutuzumab, and venetoclax) can make chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) undetectable in the body. About 230 adults who have not had prior treatment for these blood cancers w…
Matched conditions: SMALL LYMPHOCYTIC LEUKEMIA (SLL)
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 12, 2026 13:42 UTC